Currently holds a position at Collegium Pharmaceutical Inc
Position | Company | Period |
---|---|---|
Executive Vice President, Chief Commercial Officer | Collegium Pharmaceutical Inc | Aug. 1, 2018 - |
Senior Vice President of Sales, Marketing and Training | Collegium Pharmaceutical Inc | Jan. 1, 2018 - Aug. 1, 2018 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-02-28 | 2024-02-26 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
664
-0.5%
37.1524,670 USD |
664 -0.5% | 37.15 | 24,670 USD | |
2024-02-28 | 2024-02-26 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
9,336
-6.3%
36.38339,601 USD |
9,336 -6.3% | 36.38 | 339,601 USD | |
2024-01-18 | 2024-01-16 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
23,560
-17.5%
32.28760,519 USD |
23,560 -17.5% | 32.28 | 760,519 USD | |
2023-03-03 | 2023-03-01 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
13,324
-9.0%
26.70355,751 USD |
13,324 -9.0% | 26.70 | 355,751 USD | |
2023-01-11 | 2023-01-09 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
69
-0.1%
28.581,972 USD |
69 -0.1% | 28.58 | 1,972 USD | |
2023-01-11 | 2023-01-09 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
7,341
-6.7%
27.83204,300 USD |
7,341 -6.7% | 27.83 | 204,300 USD | |
2023-01-11 | 2023-01-09 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
10,424
-8.6%
27.08282,282 USD |
10,424 -8.6% | 27.08 | 282,282 USD | |
2022-02-28 | 2022-02-18 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
10,559
-8.0%
21.61228,180 USD |
10,559 -8.0% | 21.61 | 228,180 USD | |
2021-12-17 | 2021-12-15 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
5,693
-6.9%
18.33104,353 USD |
5,693 -6.9% | 18.33 | 104,353 USD | |
2021-02-12 | 2021-02-11 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
5,798
-6.5%
25.33146,863 USD |
5,798 -6.5% | 25.33 | 146,863 USD | |
2021-02-12 | 2021-02-11 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
2,100
-2.3%
24.8952,269 USD |
2,100 -2.3% | 24.89 | 52,269 USD | |
2021-01-20 | 2021-01-15 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
1,322
-2.9%
22.8930,261 USD |
1,322 -2.9% | 22.89 | 30,261 USD | |
2020-07-14 | 2020-07-13 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
1,429
-3.0%
17.0124,307 USD |
1,429 -3.0% | 17.01 | 24,307 USD | |
2020-05-20 | 2020-05-18 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
8,000
-14.2%
24.00192,000 USD |
8,000 -14.2% | 24.00 | 192,000 USD | |
2020-05-15 | 2020-05-13 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
4,434
-8.4%
22.61100,253 USD |
4,434 -8.4% | 22.61 | 100,253 USD | |
2020-01-16 | 2020-01-14 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
1,321
-3.6%
23.8731,532 USD |
1,321 -3.6% | 23.87 | 31,532 USD | |
2019-07-12 | 2019-07-11 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
2,857
-7.0%
12.3135,170 USD |
2,857 -7.0% | 12.31 | 35,170 USD |